Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis - James D. Chalmers; Pierre-Regis Burgel; Charles L. Daley; Anthony De Soyza; Charles S. Haworth; David Mauger; Michael R. Loebinger; Pamela J. McShane; Felix C. Ringshausen; Francesco Blasi; Michal Shteinberg; Kevin Mange; et al. (New England Journal of Medicine, 2025)